Share price
₹2,202.1 latest close · +53.0% over the last 90 sessions
₹2,202.1 month-end · +157.1% over 12 months
₹2,202.1 month-end · +315.2% over 3 years
₹2,202.1 month-end · +2016.4% since Jan '19
52-week range ₹710.00 to ₹2900.00 · 1-year volatility 45.9%
Was the rally earned?
Partly.
- Most of the rise came from investors paying a higher multiple (P/E 11.2x to 25.2x); per-share earnings added 22 points.
- The share count barely moved.
Mostly yes, with a catch.
- Per-share earnings added 533 points, but investors now pay less per rupee of profit (P/E 67.1x to 25.2x), which took 217 points back.
- The share count rose 5%.
Both mattered.
- Per-share earnings added 520 points and the multiple added 715 points (P/E 5.6x to 25.2x).
- The share count fell 6%.
What do "pts" mean?
"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.
Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.
Net profit is trailing twelve months as reported with a 60-day lag.
How rough has the ride been?
Drawdown from peak
Largest drawdowns
-75.3% (2020-02 peak to 2020-05 low, recovered 2022-05)
-38.3% (2022-09 peak to 2023-02 low, recovered 2023-07)
-35.7% (2019-01 peak to 2019-02 low, recovered 2019-04)
Most recent volume spikes
2026-08-27: 5.4x the 50-day median, price +4.3% that day
2026-08-26: 7.7x the 50-day median, price -1.7% that day
2026-08-24: 8.4x the 50-day median, price +4.2% that day
Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).
Is it expensive against its own past and its peers?
Usual range 4.8x to 48.1x since 2019-01.
15% below the Producer Manufacturing median.
The chart loads when you open this tab.
The chart loads when you open this tab.
How to read this
Shaded band: 10th to 90th percentile of the company's own P/E history; dotted line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).
Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.
Where does it rank among Producer Manufacturing peers?
Each cell is the company's percentile rank among its Producer Manufacturing peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Where it ranks today
- ROCE79th▲ 10 pts vs a year ago
- Op. margin78th▲ 9 pts vs a year ago
- Revenue growth64th▲ 56 pts vs a year ago
- EPS growth55th▼ 34 pts vs a year ago
- Debt/equity ↓50th▼ 9 pts vs a year ago
- Cash cycle ↓61stflat vs a year ago
- P/E ↓59th▼ 35 pts vs a year ago
- 12M momentum98th▲ 20 pts vs a year ago
Rank history
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Producer Manufacturing sector page Watch it move against Producer Manufacturing in the Observatory
What is the price implying?
At normalised P/E (five-year average earnings) of 55.0x, a holder earning 12%/yr needs earnings to grow about 26.9%/yr for 10 years, then trade at 15x.
Over time
Implied growth by month (solid) and delivered growth (dashed).
Change the assumptions
| Exit P/E / return | 11% | 12% | 13% |
|---|---|---|---|
| 12x | 28.6% | 29.7% | 30.9% |
| 15x | 25.8% | 26.9% | 28.1% |
| 20x | 22.3% | 23.4% | 24.5% |
Drag a slider to test other assumptions
Implied: 26.9%/yrLooking back
- Jan 2021Price implied 13%/yr; EPS has since grown 16%/yr (6.0 yrs)
- Jan 2022Price implied 12%/yr; EPS has since grown 14%/yr (5.0 yrs)
Past comparisons cover only companies listed today (survivorship bias) and say nothing about future outcomes.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect. How this is calculated and the market-wide lists.
What prices imply across Producer Manufacturing The market-wide Expectations lists
Key figures
- Share Priceclose 9 Nov
- ₹2202.10
- P/E
- 25.2x
- ROCE
- 23.0%
- Market Cap
- ₹58079 cr
- Revenue (TTM)
- ₹17300 cr
- P/S
- 3.4x
- P/B
- 6.3x
- ROE
- 25.2%
- Operating Margin
- 17.0%
- Debt / Equity
- 0.3x
- Promoter Holding
- 49.7%
- 12M Momentum
- 157.1%
52-week range
Price risk
Balance sheet & cash
Are profits backed by cash?
Other income reliance37%Beyond threshold
Other income as a share of pre-tax profit (trailing twelve months): 37.3%. Bands: below 15%, 15% to 35%, above 35%.
Tax rate20%Within range
Median quarterly effective tax rate over about 2.5 years: 20.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.
Cash conversion1.29xWithin range
Operating cash flow divided by net profit over the last three fiscal years: 1.29x (cash from operations ₹6,014 cr, net profit ₹4,658 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.
Free cash flow3 of 5 yrsNear threshold
Fiscal years with positive free cash flow in the last 5: 3. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history-6 daysWithin range
Debtor days are below the median of the previous three fiscal years by 6 days (37 vs 43). Bands: under 15 days, 15 to 45, over 45.
Capital work in progress19% of fixed assetsWithin range
Capital work-in-progress is 19% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days+50 days / 2 yrsNear threshold
Days payable changed by +50 over two years. Bands: rise of up to 30 days; more than 30 days.
Tap a check to see how it is measured
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
Who has been buying and selling?
- Over 3 years, DIIs added 8.4 pts; FIIs added 5.2 pts.
- The number of shareholders rose from 82,058 to 1.4 lakh (+69%) between Sep 2023 and Jun 2026.
Holdings, Jun '26
How each group changed
Number of shareholders
Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.
What happened next to similar setups
- We found 50 past situations where a non-financial company looked like WELSPUN CORP LIMITED today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
- Over the following 12 months the middle half of them returned −24% to +33% vs the market, against −4% for all non-financial companies in the same months.
- The gap against the base rate (−2.3%, 80% range −11.1% to +7.6%) is within what chance and overlapping periods produce.
Where the 50 outcomes landed
Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 5 beyond the range shown, drawn at the edge
50 past situations · 50 companies · 31 months · 2020–2025
The closest matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| USHAMART Producer Manufacturing |
Sep 2023 | 30x | 21% | +182% | −7% | −28% |
| KPRMILL Consumer Non-Durables |
Jul 2021 | 25x | 25% | +349% | −6% | +45% |
| CYIENT Technology Services |
Dec 2023 | 49x | 20% | +183% | −4% | −32% |
| SHRIPISTON Producer Manufacturing |
Apr 2024 | 31x | 25% | +257% | −6% | −14% |
| KIRLOSBROS Producer Manufacturing |
Jun 2024 | 48x | 27% | +248% | −5% | +9% |
Show the other 3 matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| TRIDENT Process Industries |
Jun 2022 | 23x | 23% | +137% | −43% | −29% |
| MARKSANS Health Technology |
Jun 2025 | 31x | 20% | +64% | −26% | +4% |
| AUROPHARMA Health Technology |
Nov 2020 | 18x | 19% | +93% | −9% | −46% |
How reliable is this?
Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: P/S, P/E and revenue growth. One match per company and at most 7 from any one month.
Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.
What else looks like this?
Companies with the most similar financial profile today, regardless of industry.
Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.
What changed?
30 events since Jun '23
- SepResultsYear-on-year EPS growth turned positive.
- SepPeer rankMoved into the top quartile of Producer Manufacturing on operating margin (from the 2nd quartile).
- AugPriceVolume reached 27.9x its 50-day median on 2026-08-21; price +15.3% that day.
- JunResultsYear-on-year EPS growth turned negative.
- JunPeer rankMoved into the top quartile of Producer Manufacturing on ROCE (from the 2nd quartile).
- AprPriceRegained the 2025-06 peak, 3 months after the low.
- AprPriceVolume reached 9.7x its 50-day median on 2026-04-23; price +5.7% that day.
- MarPeer rankSlipped to the 2nd quartile of Producer Manufacturing on EPS growth (from the top quartile).
Show 22 earlier events
- MarDebtDebt / equity halved over 12 months to 0.15x.
- JanPriceFell 25% from the Jun 2025 peak to the Jan 2026 low.
- JanPriceVolume reached 7.8x its 50-day median on 2026-01-19; price +6.9% that day.
- OctPriceVolume reached 24.7x its 50-day median on 2025-10-31; price +4.3% that day.
- AugDebtDebt / equity halved over 12 months to 0.15x.
- JulPriceVolume reached 5.5x its 50-day median on 2025-07-02; price +2.9% that day.
- MayPriceVolume reached 35.2x its 50-day median on 2025-05-29; price +10.0% that day.
- MarInstitutionsFII + DII holding rose 11.7 pts over 2 quarters to 31.9%.
- MarPriceVolume reached 8.0x its 50-day median on 2025-03-20; price +7.7% that day.
- JanDebtDebt / equity halved over 12 months to 0.35x.
- JulPriceRegained the 2024-05 peak, 1 month after the low.
- JunResultsYear-on-year EPS growth turned positive.
- JunPriceFell 25% from the May 2024 peak to the Jun 2024 low.
- JunPeer rankMoved into the 2nd quartile of Producer Manufacturing on ROCE (from the bottom quartile).
- JunDebtDebt / equity halved over 12 months to 0.35x.
- JunDividendDividend payout cut from 63% to 12% of profit.
- MayPriceVolume reached 9.5x its 50-day median on 2024-05-02; price +7.2% that day.
- NovPriceVolume reached 8.4x its 50-day median on 2023-11-09; price +5.0% that day.
- JulPriceRegained the 2022-09 peak, 5 months after the low.
- JulPriceVolume reached 6.8x its 50-day median on 2023-07-05; price +7.0% that day.
- JunValuationP/E crossed above the 90th percentile of its own history to date (33.0x).
- JunPeer rankSlipped to the bottom quartile of Producer Manufacturing on ROCE (from the 3rd quartile).
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Monthly history60 months · 2021-12 to 2026-11
| Month | P/E | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|---|
| 2026-11 | 25.2x | ₹17300 cr | 25.2% | 23.0% | 0.3x |
| 2026-10 | 26.7x | ₹17300 cr | 25.3% | 23.0% | 0.3x |
| 2026-09 | 31.0x | ₹17300 cr | 25.3% | 23.0% | 0.3x |
| 2026-08 | 39.1x | ₹16770 cr | 17.7% | 23.0% | 0.3x |
| 2026-07 | 27.0x | ₹16770 cr | 17.7% | 23.0% | 0.3x |
| 2026-06 | 24.9x | ₹16770 cr | 17.7% | 23.0% | 0.3x |
| 2026-05 | 18.7x | ₹16382 cr | 26.2% | 21.0% | 0.2x |
| 2026-04 | 17.2x | ₹16382 cr | 26.2% | 21.0% | 0.2x |
| 2026-03 | 11.0x | ₹16382 cr | 26.2% | 21.0% | 0.2x |
| 2026-02 | 10.0x | ₹15464 cr | 29.1% | 21.0% | 0.2x |
| 2026-01 | 8.9x | ₹15464 cr | 29.1% | 21.0% | 0.2x |
| 2025-12 | 9.9x | ₹15464 cr | 29.1% | 21.0% | 0.2x |
| 2025-11 | 11.2x | ₹14392 cr | 26.9% | 21.0% | 0.2x |
| 2025-10 | 12.6x | ₹14392 cr | 26.9% | 21.0% | 0.2x |
| 2025-09 | 11.2x | ₹14392 cr | 26.9% | 21.0% | 0.2x |
| 2025-08 | 11.6x | ₹13978 cr | 25.6% | 21.0% | 0.2x |
| 2025-07 | 12.8x | ₹13978 cr | 25.6% | 21.0% | 0.2x |
| 2025-06 | 12.7x | ₹13978 cr | 25.6% | 21.0% | 0.2x |
| 2025-05 | 16.6x | ₹14514 cr | 26.6% | 20.0% | 0.4x |
| 2025-04 | 13.6x | ₹14514 cr | 26.6% | 20.0% | 0.4x |
| 2025-03 | 15.4x | ₹14514 cr | 26.6% | 20.0% | 0.4x |
| 2025-02 | 17.6x | ₹15650 cr | 19.9% | 20.0% | 0.4x |
| 2025-01 | 17.8x | ₹15650 cr | 19.9% | 20.0% | 0.4x |
| 2024-12 | 19.5x | ₹15650 cr | 19.9% | 20.0% | 0.4x |
| 2024-11 | 17.0x | ₹16407 cr | 21.7% | 20.0% | 0.4x |
| 2024-10 | 16.0x | ₹16407 cr | 21.7% | 20.0% | 0.4x |
| 2024-09 | 16.8x | ₹16407 cr | 21.7% | 20.0% | 0.4x |
| 2024-08 | 16.7x | ₹17340 cr | 20.3% | 20.0% | 0.4x |
| 2024-07 | 15.1x | ₹17340 cr | 20.3% | 20.0% | 0.4x |
| 2024-06 | 12.9x | ₹17340 cr | 20.3% | 20.0% | 0.4x |
| 2024-05 | 69.5x | ₹9758 cr | 4.2% | 6.0% | 0.7x |
| 2024-04 | 71.4x | ₹9758 cr | 4.2% | 6.0% | 0.7x |
| 2024-03 | 65.2x | ₹9758 cr | 4.2% | 6.0% | 0.7x |
| 2024-02 | 64.6x | ₹9758 cr | 4.2% | 6.0% | 0.7x |
| 2024-01 | 74.4x | ₹9758 cr | 4.2% | 6.0% | 0.7x |
| 2023-12 | 69.4x | ₹9758 cr | 4.2% | 6.0% | 0.7x |
| 2023-11 | 67.1x | ₹9758 cr | 4.2% | 6.0% | 0.7x |
| 2023-10 | 53.8x | ₹9758 cr | 4.2% | 6.0% | 0.7x |
| 2023-09 | 49.8x | ₹9758 cr | 4.2% | 6.0% | 0.7x |
| 2023-08 | 41.4x | ₹9758 cr | 4.2% | 6.0% | 0.7x |
| 2023-07 | 40.8x | ₹9758 cr | 4.2% | 6.0% | 0.7x |
| 2023-06 | 33.0x | ₹9758 cr | 4.2% | 6.0% | 0.7x |
| 2023-05 | 15.0x | ₹6505 cr | 10.0% | 13.0% | 0.5x |
| 2023-04 | 13.4x | ₹6505 cr | 10.0% | 13.0% | 0.5x |
| 2023-03 | 11.9x | ₹6505 cr | 10.0% | 13.0% | 0.5x |
| 2023-02 | 11.0x | ₹6505 cr | 10.0% | 13.0% | 0.5x |
| 2023-01 | 12.5x | ₹6505 cr | 10.0% | 13.0% | 0.5x |
| 2022-12 | 14.1x | ₹6505 cr | 10.0% | 13.0% | 0.5x |
| 2022-11 | 14.9x | ₹6505 cr | 10.0% | 13.0% | 0.5x |
| 2022-10 | 13.2x | ₹6505 cr | 10.0% | 13.0% | 0.5x |
| 2022-09 | 15.8x | ₹6505 cr | 10.0% | 13.0% | 0.5x |
| 2022-08 | 13.5x | ₹6505 cr | 10.0% | 13.0% | 0.5x |
| 2022-07 | 13.4x | ₹6505 cr | 10.0% | 13.0% | 0.5x |
| 2022-06 | 13.0x | ₹6505 cr | 10.0% | 13.0% | 0.5x |
| 2022-05 | 7.7x | ₹7153 cr | 20.3% | 20.0% | 0.3x |
| 2022-04 | 7.0x | ₹7153 cr | 20.3% | 20.0% | 0.3x |
| 2022-03 | 5.7x | ₹7153 cr | 20.3% | 20.0% | 0.3x |
| 2022-02 | 4.8x | ₹7153 cr | 20.3% | 20.0% | 0.3x |
| 2022-01 | 6.3x | ₹7153 cr | 20.3% | 20.0% | 0.3x |
| 2021-12 | 6.1x | ₹7153 cr | 20.3% | 20.0% | 0.3x |
Older months are in the live observatory.